A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource

June 2016 summary of the new medications added to Medicare Part D plan formularies (drug lists)

Category: Monthly Formulary Changes
Published: Jul, 02 2016 09:07:18

The June, 2016 Medicare Part D plan formulary data (or drug lists) includes the addition of 32 new National Drug Codes (NDC) to the Medicare Part D program.  These NDCs represent 23 different drugs, many with multiple strengths.

A special note about the new generic for the brand-name drug Gleevec®
Imatinib Mesylate, the generic for the cancer medication Gleevec was recently added to many 2016 Medicare Part D formularies.  For example, in California, 23 stand-alone Medicare Part D plans now cover the generic Imatinib Mesylate (100 mg) and 28 stand-alone Medicare Part D plans cover the brand-name Gleevec (100 mg). 
Unfortunately, the retail price for the generic is not much different (less) than the brand-name Gleevec medication.  Retail prices in California for generic Imatinib Mesylate range from $1,743.11 to $2,847.72 , while retail prices in California for brand-name Gleevec range from $2,792.26 to $2,869.96 - depending on the chosen Medicare Part D plan.  As a comparison, in September 2010, the monthly retail price for Gleevec was around $1,260.
Cost-sharing for either the generic or brand-name medication can range from 25% of retail to 33% of retail.  And, because of the generic or brand-name drug's high retail cost, the second monthly purchase will place you in the Donut Hole and the third or fourth monthly purchase will mean that you are through the Donut Hole and in the Catastrophic Coverage portion of your Medicare Part D plan and will pay 5% of the retail cost for the remainder of the year.

What are National Drug Codes or NDCs?
As a reminder, the NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

There are many reasons for NDCs to be added to the Medicare Part D program, a summary is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 4
New Drug 2
New Drug and Strength 11
New Manufacturer 1
New Manufacturer and Delivery Form 1
New Manufacturer and Strength 6
New Manufacturer, Strength and Delivery Form
New Strength 4
New Strength and Delivery Form
Total New NDCs 32

The following chart details the 32 new manufacturer / drug / strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
67457059400 ARIXTRA 7.5 MG/0.6 ML SYRINGE New Strength
13551012501 CEFACLOR SUS 125 MG/5ML New Manufacturer and Strength
00069047103 CHANTIX STARTING MONTH BOX New Delivery Form
00713031788 CICLOPIROX 8% SOLUTION New Manufacturer and Strength
68968051408 COMBIPATCH 0.05-0.14 MG PTCH New Manufacturer and Strength
00172640649 CROMOLYN 20 MG/2 ML NEB SOLN New Manufacturer and Strength
60432065104 DOXEPIN 10 MG/ML ORAL CONC New Manufacturer and Delivery Form
40076023060 ELIMITE 5 % CREAM New Drug
43068011304 FANAPT TITR TABLETS New Strength
00143966601 Fluconazole 400 MG/ 200 ML Injectable Solution New Manufacturer and Strength
68180082709 FYAVOLV 0.5 MG-2.5 MCG TABLET New Drug and Strength
68180082809 FYAVOLV 1 MG-5 MCG TABLET New Drug and Strength
47335047281 IMATINIB MESYLATE 100 MG TABLET [Gleevec] New Drug and Strength
47335047583 IMATINIB MESYLATE 400 MG TABLET [Gleevec] New Drug and Strength
24208080060 LACRISERT 5 MG INS New Drug
61748040102 LINDANE 1% LOTION New Manufacturer, Strength and Delivery Form
00115147046 MOMETASONE FUROATE 0.1% CREAM New Delivery Form
50242007401 NUTROPIN AQ NUSPIN 10 INJECTOR New Strength and Delivery Form
50242007601 NUTROPIN AQ NUSPIN 20 INJECTOR New Strength and Delivery Form
17478071310 OFLOXACIN 0.3 % DRP New Manufacturer
64406001601 PLEGRIDY SYRINGE STARTER PACK New Delivery Form
64406001101 PLEGRIDY 125 MCG/0.5 ML PEN New Delivery Form
31722090990 PRAMIPEXOLE 0.75 MG TABLET New Manufacturer and Strength
24478012001 QUILLICHEW ER 20 MG CHEW TAB New Drug and Strength
24478013001 QUILLICHEW ER 30 MG CHEW TAB New Drug and Strength
24478014001 QUILLICHEW ER 40 MG CHEW TAB New Drug and Strength
00409508411 TAZICEF 2 GRAM VIAL New Strength
52244040010 THEO-24 ER 400 MG CAPSULE New Strength
61874011530 VRAYLAR 1.5 MG CAP New Drug and Strength
61874013030 VRAYLAR 3 MG CAP New Drug and Strength
61874014530 VRAYLAR 4.5 MG CAP New Drug and Strength
61874016030 VRAYLAR 6 MG CAP New Drug and Strength

You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at Q1Medicare.com/FormularyBrowser or compare how any medication is covered on all Medicare plans in your service area using our Q1Medicare.com/DrugFinder.

Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs

Find Prescription Discounts
Prescription Discounts are
easy as 1-2-3
  1. Locate lowest price drug and pharmacy
  2. Show card at pharmacy
  3. Get instant savings!
Your drug discount card is available to you at no cost.

Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.